Ligand ID: SFY Drugbank ID: DB00891(Sulfapyridine) Indication:For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.73A | 22.43 | DMS A 401 ( 4.9A)NoneDMS A 401 (-3.9A)NoneNone | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.66A | 22.43 | NoneNoneN0A D 2 ( 4.0A)NoneNone | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU B 167PHE B 134MET B 165ALA B 173MET B 130 | 1.72A | 22.94 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.67A | 22.94 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.70A | 22.94 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU D 57PHE D 54TYR D 88PRO D 163ALA D 174 | 1.54A | 18.03 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 11 | LEU D 57PHE D 54TYR D 88PRO D 163ALA D 174 | 1.55A | 18.03 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 731LEU A 207PHE A 45TYR A 732PRO A 243 | 1.78A | 15.26 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 731LEU A 207PHE A 45TYR A 732PRO A 243 | 1.78A | 15.26 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.75A | 22.94 | NoneNoneX77 A 401 (-3.9A)NoneNone | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 12 | PHE D4321PRO D4353MET D4316GLN D4318ALA D4314 | 1.74A | 17.69 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6wjt | NSP10 (SARS-CoV-2) | 5 / 12 | PHE D4321PRO D4353MET D4316GLN D4318ALA D4314 | 1.76A | 17.69 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6wkq | NSP10 (SARS-CoV-2) | 5 / 12 | PHE D4321PRO D4353MET D4316GLN D4318ALA D4314 | 1.75A | 17.69 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.74A | 22.94 | U5G A 401 (-3.9A)NoneU5G A 401 (-3.5A)NoneNone | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.69A | 22.94 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.63A | 22.94 | NoneNoneO6K A 402 ( 4.2A)NoneNone | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 16PHE A 13TYR A 47PRO A 122ALA A 133 | 1.56A | 17.54 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 11 | LEU A 16PHE A 13TYR A 47PRO A 122ALA A 133 | 1.56A | 17.54 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 11 | LEU A 16PHE A 13TYR A 47PRO A 122ALA A 133 | 1.57A | 17.54 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.72A | 22.15 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.62A | 22.15 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.76A | 22.94 | None | ||
![]() | 4HWK_A_SFYA807_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.79A | 16.54 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.76A | 15.26 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.76A | 15.26 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.79A | 16.54 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.77A | 15.26 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 731SER A 239PHE A 45TYR A 732PRO A 243 | 1.72A | 15.26 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.78A | 16.54 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.79A | 16.54 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 167PHE A 134MET A 165ALA A 173MET A 130 | 1.69A | 22.94 | DMS A 405 ( 4.9A)NoneJRY A 401 ( 3.9A)NoneNone | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.63A | 15.07 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.74A | 14.93 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.75A | 14.93 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.64A | 15.07 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.64A | 15.07 | None | ||
![]() | 4HWK_A_SFYA807_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.64A | 15.07 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.75A | 14.93 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.59A | 15.07 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.58A | 15.07 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.79A | 14.93 | None | ||
![]() | 4HWK_D_SFYD803_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.78A | 14.93 | None | ||
![]() | 4HWK_C_SFYC804_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.59A | 15.07 | None | ||
![]() | 4HWK_B_SFYB806_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 186LEU A 240TYR A 238GLN A 210ALA A 185 | 1.79A | 14.93 | None | ||
![]() | 4HWK_A_SFYA807_0 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | SER C 4CYH C 8PHE A 843TYR A 420ALA A 423 | 1.59A | 15.07 | None |